![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista delle Categorie
AlcolismoAlzheimer E ParkinsonAnalgesiciAntiallergicoAntibioticiAnticonvulsiviAntidepressiviAntimicoticiAntinfiammatoriAntiparassitariaAntiviraliApparato RespiratorioArtriteAsmaChirurgiaColesteroloContraccettivoCura Della PelleCura Per Gli OcchiDiabeteDisfunzione ErettileDisordini MentaliDiureticiEmicraniaFarmaci Anti- H I VMalattie CardiovascolariMalattie Genito-urinarieMalattie NeurologicheOsteoporosiPerdita Di PesoPressione Arteriosa SistemicaRilassanti MuscolariSalute Dell' UomoSalute Della DonnaTratto GastrointestinaleTumore 22 May 2012 21:23:10
Celebrex creator Talley working on a new anti-inflammatory drug for cancerCelebrex creator Talley working on a new anti-inflammatory drug for cancer MedCity News In his latest project, Dr. John Talley, the lead scientist behind Pfizer's Celebrex and seven other drugs that have been marketed in the US, is trying his hand at developing a cancer medication with improved efficacy and safety.
16 May 2012 09:00:34
For the Treatment of Osteoarthritic Pain, Clinical Data and Interviewed ...For the Treatment of Osteoarthritic Pain, Clinical Data and Interviewed ... EON: Enhanced Online News (press release) Clinical data and the opinions of interviewed thought leaders indicate that Pfizer's tanezumab has advantages on this attribute over Pfizer's Celebrex , the sales-leading agent for osteoarthritic pain. The DecisionBase 2012 report entitled ...
16 May 2012 05:43:30
Decreased Risk for Upper, Lower GI Events With COX-2 Inhibitor Compared With ...Decreased Risk for Upper, Lower GI Events With COX-2 Inhibitor Compared With ... Pain Medicine News by Ted Bosworth National Harbor, Md.â A large randomized, â real-worldâ study demonstrated that celecoxib ( Celebrex , Pfizer) is associated with a lower risk for upper and lower gastrointestinal (GI) events compared with nonselective nonsteroidal ...
15 May 2012 15:01:46
For the Treatment of Osteoarthritic Pain, Clinical Data and Interviewed ...For the Treatment of Osteoarthritic Pain, Clinical Data and Interviewed ... MarketWatch (press release) Clinical data and the opinions of interviewed thought leaders indicate that Pfizer's tanezumab has advantages on this attribute over Pfizer's Celebrex , the sales-leading agent for osteoarthritic pain. The DecisionBase 2012 report entitled ...
03 May 2012 00:11:34
Religion news in briefReligion news in brief Fox News Pfizer settles BYU lawsuit for $450 million, suit over credit for developing painkiller Celebrex SALT LAKE CITY (AP) â Pfizer Inc. has settled a lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex for ...
02 May 2012 22:05:02
Scientists Spot How Cox-2 Painkillers Raise Heart Risks Science Codex Scientists Spot How Cox-2 Painkillers Raise Heart Risks U.S. News & World Report Meanwhile, Celebrex , a painkiller in the same drug class that remains on the market, carries a "black box" warning alerting patients to potential heart risks. Now, a team of scientists from the University of Pennsylvania in Philadelphia say that, ... WSJ BLOG Health: Studies Shine Light on How Vioxx Raises Heart Risks02 May 2012 20:02:55
Studies Shine Light on How Vioxx Raises Heart RisksStudies Shine Light on How Vioxx Raises Heart Risks Wall Street Journal (blog) The label for Pfizer's Celebrex , the only drug in the class still on the market, warns about the risks. These drugs aimed to provide pain relief without causing the bleeding ulcers that could result from taking other painkillers. How pain medication ups heart disease risk COX-2 Mystery Cleared Up
02 May 2012 13:58:02
Pfizer settles lawsuit involving CelebrexPfizer settles lawsuit involving Celebrex Atlanta Journal Constitution By PAUL FOY AP SALT LAKE CITY â Pfizer Inc. has settled a lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex for $450 million, according to a regulatory filing Tuesday. Terms of the settlement weren't ...
|
|
Choose Your language:
Cerca nel sito:
Testimonianze
Grazie molto per la vostra gentile email,che spiega ogni cosa. E per il vostro continuo buon servizio,che ha ,francamente, salvato i miei rapporti con la donna che amo.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| I più venduti|Politiche|Domande frequenti|Testimonianze|Contatti|Sitemap |
|
|
|
|
| |